AHA video: Consent reform can make patient informed consumers

TriMed Staff | | Cardiovascular Business | Interventional Cardiology
AHA: PRISM - 30.62 Mb
John Spertus MD, MPH, principal investigator of PRISM, spoke with Cardiovascular Business about the findings of his 2011 AHA late-breaking clinical trial. Source: MyHealthOutcomes
ORLANDO, Fla.— John Spertus, MD, MPH, principal investigator of the late-breaking clinical trial, PRISM, reviewed a new way to approach the consent form process that allows for greater dialogue between patients and physicians for combined decision-making with Cardiovascular Business.

In the trial evaluating this new consent form process, the researchers found that it is feasible to implement evidence-based decision aids within the routine flow of patient care. The trial was presented Nov. 14 at the 2011 American Heart Association (AHA) conference. Spertus explained the potential implications to the patient and the hospital.

This video was conducted collaboratively with ClinicalTrialResults.org.

TriMed Staff

Related Content

Surgery outperforms PCI in NSTEMI patients with multivessel CAD
Boston Scientific enters IVL arms race with acquisition worth up to $664M
FDA sees value in no-implant heart failure device
Radial secondary access during TAVR limits complications
Medtronic’s Harmony TPVR system gains CE mark approval
History made: Young child treated with new heart device for very first time

Around the web

Radiology Business
Key takeaways from RSNA 2024 for AI, CT, MRI and the radiology staffing shortage

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.